| CD44 |
IPI00305064 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
0.477 |
Evidence |
|
| MAPK14 |
MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
0.477 |
Evidence |
|
| TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
JAK1 |
|
0.477 |
Evidence |
|
| TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.477 |
Evidence |
|
| FLT4 |
VEGFR3 long form |
JAK1 |
|
0.477 |
Evidence |
|
| FLT4 |
VEGFR3 long form |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.477 |
Evidence |
|
| VAV2 |
VAV2: Uncharacterized protein VAV2 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.477 |
Evidence |
|
| VAV2 |
VAV2: Uncharacterized protein VAV2 |
JAK1 |
|
0.477 |
Evidence |
|
| VAV2 |
VAV2: Uncharacterized protein VAV2 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.477 |
Evidence |
|
| VAV2 |
VAV2: Uncharacterized protein VAV2 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| LYN |
LYN: Tyrosine-protein kinase Lyn |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| LYN |
LYN: Tyrosine-protein kinase Lyn |
FLT4 |
VEGFR3 long form |
0.477 |
Evidence |
|
| LYN |
LYN: Tyrosine-protein kinase Lyn |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| STAT3 |
|
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| ALK |
ALK: ALK tyrosine kinase receptor precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
MAPK14 |
MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14 |
0.477 |
Evidence |
|
| SLC9A7 |
SLC9A7, NHE7: Sodium/hydrogen exchanger 7 |
SCAMP1 |
SCAMP1, SCAMP: Secretory carrier-associated membrane protein 1 |
0.477 |
Evidence |
|
| SSH2 |
SSH2, KIAA1725, SSH2L: Protein phosphatase Slingshot homolog 2 |
MAPK14 |
MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14 |
0.477 |
Evidence |
|
| EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| RABEP1 |
RABEP1, RABPT5, RABPT5A: Rab GTPase-binding effector protein 1 |
GGA3 |
GGA3, KIAA0154: ADP-ribosylation factor-binding protein GGA3 |
0.477 |
Evidence |
|
| STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
FLT4 |
VEGFR3 long form |
0.477 |
Evidence |
|
| PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
VAV2 |
VAV2: Uncharacterized protein VAV2 |
0.477 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
TNK2 |
TNK2, ACK1: Activated CDC42 kinase 1 |
0.477 |
Evidence |
|